A Clinical Study To Evaluate The Therapeutic Effect of Lekhana Basti(Yoga Basti) And Gomutra Hareetaki Orally In Uterine Fibroid

A Clinical Study To Evaluate The Therapeutic Effect of Lekhana Basti And Gomutra Hareetaki Orally In Uterine Fibroid

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/01/048961

Enrollment

Registered

2023-01-12

Start date

Unknown

Completion date

Unknown

Last updated

2023-02-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N945- Secondary dysmenorrhea

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: FIBROID SIZE LESS THAN 5CM MARRIED SUBJECTS FIT FOR LEKHANA BASTI

Exclusion criteria

Exclusion criteria: HB LESS THAN 9GM% PREGNANT AND LACTATING WOMEN SYSTEMIC DISEASES INTERVENING THE TREATMENT MALIGNANT CONDITIONS POST MENOPAUSAL PERIOD SUBJECTS UNDERGOING HORMONAL THERAPY

Design outcomes

Primary

Measure	Time frame
Symptomatic changes along with size of FibroidTimepoint: One month	—

Secondary

Measure	Time frame
SIZE OF FIBROIDTimepoint: 81 DAYS	—

Countries

India

Contacts

Public ContactDR ARPANA JAIN

SRI DHARMASTHALA MANJUNATHESHWARA COLLEGE OF AYURVEDA

arpanajainsdm@gmail.com9880288577

Outcome results